PALI PALISADE BIO, INC.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $195.2M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $37.1K | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $38.9K | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $28.8K | $192 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $16.4K | $0 |
| 2024-Q2 | $9.7K | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $17.8K | $10.3K |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $250.2K | $409.9K |
| 2026-Q4 | $28.8K | $0 |
Bought$427.6K25 buy days
Sold$420.4K5 sell days
Net insider flow+$7.2Knet buying · 5 years
Latest trade2026-10-02Williams Donald Allen
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Buy | Williams Donald Allen | Director | 10,000 | $1.46 | $14.6K | 1 |
| 2026-10-01 | Buy | Williams Donald Allen | Director | 10,000 | $1.42 | $14.2K | 1 |
| 2026-07-09 | Buy | Baltera Robert Jr. | Director | 25,000 | $1.96 | $48.9K | 1 |
| 2026-07-08 | Buy | Baltera Robert Jr. | Director | 20,000 | $1.99 | $39.8K | 1 |
| 2026-07-07 | Sell | Finley John David | CEO | 146,798 | $2.07 | $303.3K | 1 |
| 2026-07-07 | Sell | Jones Mitchell Lawrence | Other C-suite | 51,880 | $2.05 | $106.5K | 1 |
| 2026-07-07 | Buy | Baltera Robert Jr. | Director | 30,000 | $2.03 | $61.0K | 1 |
| 2026-07-06 | Buy | Baltera Robert Jr. | Director | 20,000 | $2.05 | $41.0K | 1 |
| 2026-07-02 | Buy | Baltera Robert Jr. | Director | 10,000 | $1.98 | $19.8K | 1 |
| 2026-07-01 | Buy | Baltera Robert Jr. | Director | 20,000 | $1.98 | $39.6K | 1 |
| 2026-02-12 | Sell | Finley John David | CEO | 3,896 | $1.75 | $6.8K | 1 |
| 2026-02-12 | Sell | Jones Mitchell Lawrence | Other C-suite | 1,989 | $1.75 | $3.5K | 1 |
| 2026-01-16 | Buy | Williams Donald Allen | Director | 5,000 | $1.67 | $8.4K | 1 |
| 2026-01-09 | Buy | Williams Donald Allen | Director | 5,000 | $1.88 | $9.4K | 1 |
| 2024-05-28 | Buy | Williams Donald Allen | Director | 1,000 | $4.86 | $4.9K | 1 |
| 2024-05-24 | Buy | Finley John David | CEO | 1,000 | $4.81 | $4.8K | 1 |
| 2024-02-06 | Buy | Finley John David | CEO | 10,000 | $0.47 | $4.7K | 1 |
| 2024-01-31 | Buy | Williams Donald Allen | Director | 10,000 | $0.61 | $6.1K | 1 |
| 2024-01-31 | Buy | Finley John David | CEO | 10,000 | $0.56 | $5.6K | 1 |
| 2023-09-27 | Buy | Williams Donald Allen | Director | 20,000 | $0.54 | $10.8K | 1 |
| 2023-09-27 | Buy | Finley John David | CEO | 15,000 | $0.54 | $8.1K | 1 |
| 2023-09-14 | Sell | Trenschel Robert J. | Director | 300 | $0.64 | $192 | 1 |
| 2023-09-13 | Buy | Finley John David | CEO | 15,000 | $0.66 | $9.9K | 1 |
| 2022-09-01 | Buy | Finley John David | CFO | 19,481 | $0.14 | $2.7K | 1 |
| 2022-08-23 | Buy | Finley John David | CFO | 7,350 | $0.16 | $1.2K | 1 |
| 2022-08-16 | Buy | Finley John David | CFO | 100,000 | $0.25 | $25.0K | 1 |
| 2022-08-16 | Buy | Hallam Thomas | CEO | 40,000 | $0.25 | $10.0K | 1 |
| 2022-03-29 | Buy | Dawson Michael John | Other C-suite | 15,000 | $1.14 | $17.1K | 1 |
| 2022-03-28 | Buy | Hallam Thomas | CEO | 10,000 | $1.18 | $11.8K | 1 |
| 2022-03-24 | Buy | Finley John David | CFO | 7,500 | $1.09 | $8.2K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Finley John David | CEO | $70.2K | $310.2K | 2026-07-07 |
| Baltera Robert Jr. | Director | $250.2K | $0 | 2026-07-09 |
| Jones Mitchell Lawrence | Other C-suite | $0 | $110.0K | 2026-07-07 |
| Williams Donald Allen | Director | $68.3K | $0 | 2026-10-02 |
| Hallam Thomas | CEO | $21.8K | $0 | 2022-08-16 |
| Dawson Michael John | Other C-suite | $17.1K | $0 | 2022-03-29 |
| Trenschel Robert J. | Director | $0 | $192 | 2023-09-14 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2022-03-24 → 2022-03-29 | 3 | $37.1K | 47 | -25.7% (-35.5% raw) | -48.0% (-65.0% raw) | -71.6% (-91.3% raw) | closed |
| 2021-08-27 → 2021-09-21 | 3 | $88.6K | 49 | +6.1% (+8.7% raw) | -31.0% (-31.2% raw) | -46.7% (-53.3% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.